Novaurum Biosciences
Somerville
About Novaurum Biosciences
Novaurum Bioscience develops AuPEC, a cell-based encapsulation technology for implanted medical devices. This innovation combines microbiology and nanotechnology to create nano-biological coatings that reduce infection rates and promote healing in orthopedic implants.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $555.0K
- Funding stage: Seed
- Last round: Grant (Mar 2025)
- Website: novaurum.bio
- Phone: +1 6179924777
Industries & Categories
Biotechnology, Medical, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/novaurum-biosciences-40246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.